Skip to main content
. 2022 Jul 26;20:345. doi: 10.1186/s12951-022-01545-z

Fig. 6.

Fig. 6

PC7A nanovaccine activated the STING pathway and inhibited tumor growth. A Schematic of the design and mechanism of the PC7A nanovaccine. B p-TBK1 is recruited into the STING–PC7A condensates. Reproduced with permission [98].

Copyright 2021 The Author(s), under exclusive licence to Springer Nature Limited. C Tumor growth inhibition study of B16F10 melanoma [97]. Copyright 2017 Nature Publishing Group